التفاصيل البيبلوغرافية
| العنوان: |
The Immunoregulatory Effect of Aconite Treatment on H22 Tumor-Bearing Mice via Modulating Adaptive Immunity and Natural Killer-Related Immunity. |
| المؤلفون: |
Wang, Huan, Qi, Xiu zhong, Jia, Wentao, Yu, Jiahui, Yang, Kangdi, Zhang, Xu, Wang, Lina |
| المصدر: |
Evidence-based Complementary & Alternative Medicine (eCAM); 1/30/2023, Vol. 2023, p1-10, 10p, 1 Diagram, 2 Charts, 6 Graphs |
| مصطلحات موضوعية: |
ACONITE, HERBAL medicine, ANIMAL experimentation, KILLER cells, ANTINEOPLASTIC agents, CELL receptors, CANCER patients, INTERFERONS, IMMUNITY, DOSE-effect relationship in pharmacology, RESEARCH funding, GLYCOPROTEINS, T cells, TUMOR markers, MEMBRANE proteins, HEPATOCELLULAR carcinoma, CHINESE medicine, MICE, ANTIGENS, PHARMACODYNAMICS, DRUG administration, DRUG dosage |
| مستخلص: |
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and, in its advanced stages, has a 5-year survival rate of only 3% to 5%. Despite novel mechanisms and treatments being uncovered over the past few years, effective strategies for HCC are currently limited. Previous studies have proven that aconite can suppress tumor growth and progression and prevent the recurrence and metastasis of multiple cancers, but the underlying molecular mechanisms are largely unknown. In this study, different doses of aconite were applied to mice bearing subcutaneous HCC tumors. It was found that aconite had a therapeutic effect on H22 tumor-bearing mice in a dose-dependent manner by reducing tumor volumes and prolonging survival times, which could be attributed to the immunoregulatory effect of aconite. Furthermore, results showed that high-dose administration of aconite could enhance adaptive immunity and natural killer (NK) cell-mediated immunity by regulating the secretion of interferon-γ, upregulating T cells and NK cells, and modulating the expression of the NK cytotoxicity biomarker CD107a and the inhibitory receptor TIGIT. This study revealed a novel mechanism through which aconite exerts antitumor effects, not merely through apoptosis induction pathways, providing more sound evidence that aconite has the potential to be developed into an effective anti-HCC agent. [ABSTRACT FROM AUTHOR] |
|
Copyright of Evidence-based Complementary & Alternative Medicine (eCAM) is the property of Hindawi Limited and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder